AEGiS-NEWSDAY: AIDS Vaccines May Miss Mark; Infectious HIV overlooked NewsdayImportant note: Information in this article was accurate in 1993. The state of the art may have changed since the publication date.
Click here to return to Newsday main menu
DonateNow


AIDS Vaccines May Miss Mark; Infectious HIV overlooked

Newsday - August 27, 1993
Laurie Garrett - Staff Writer


Vaccines now being developed to prevent AIDS may be targeting the wrong types of AIDS viruses, a leading New York City research team reports today.

AIDS-infected people are known to have a mix of human immunodeficiency viruses in their bodies. In a study of seven New Yorkers, the researchers found that only one class of the viruses could pass to another person by sexual contact. Once inside the recipient's body, however, most of these viruses mutated into a non-infectious, but more deadly form of HIV that actually caused illness.

All potential AIDS vaccines currently under development are designed to stop the later stage viruses - not the infectious types, according to Dr. David Ho, who discovered this pattern of viral mutation in research done at the Aaron Diamond AIDS Research Laboratory in Manhattan.

That might be good for therapeutic vaccines, intended for use by thosealready infected. But it's bad news if the goal of vaccination is to prevent infection in the first place, Ho said.

"It's a particularly sensitive issue," Ho said. "We better wake up to this and cover that gap fast. There is a glaring defect there that we better do something about right away."

Ho said the finding, reported in the journal Science, has strong implications for treatment as well. Nearly all test tube experiments with potential AIDS drugs have been performed on the later stage viruses because they are the only ones that grow rapidly and multiply in the laboratory. Drugs have been tested to see how well they slow that growth.

But treatment of people in the early stages of infection should be designed to target the slower-growing transmissible forms of the virus, Ho said.

"We went through this in the laboratory with CD4," Ho said, referring to a therapy that looked promising in test tube studies but failed when tried three years ago on people in early stages of HIV disease, when the virus might be easier to control. "It failed in patients because all of the laboratory work was done on [late stage] HIV variants."

Ho's finding is in line with a host of studies from the Netherlands, France and the United States. But the new research is the first to link only the milder class to transmission.

Ho and his colleagues studied human immunodeficiency viruses found in the bodies of three New York City gay men, two women and their two male sexual partners..

The researchers found only one class of HIV viruses - those that were weakest in terms of damaging the body - were passed sexually from one person to another. In some cases, the transmissible form represented less than 5 percent of all HIV types found in the swarm that infected the original individual who passed the virus on.

Ho suspects that the reason some forms of HIV are infectious is that they have the genetic ability to get inside the recipient's macrophages - large white blood cells that inhabit mucousal areas, such as the vaginal lining. Later forms of the virus can't infect macrophages, he said, but have widespread deadly effects on the rest of the immune system.
930827
ND930801


Copyright © 1993 - Newsday. All rights reserved. All pages of newsday.com are copyright © Newsday, Inc. Other parties may also own rights to portions of newsday.com content. No portion of newsday.com content may be published, broadcast or distributed, directly or indirectly, in any medium without Newsday's prior written consent. Newsday, Inc. will not be held liable for any delays, inaccuracies, errors or omissions in any content on newsday.com. http://www.newsday.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .